BN Business News
Add your company to Business Communicator →

Business · 02/04/20121 min read

FDA Corrects Classification of Norovirus Serological Reagents

The Food and Drug Administration (FDA) has corrected its previous classification of norovirus serological reagents, moving them from class III to class II, due to the need for special controls to ensure the safety and effectiveness of these devices, as mandated by the FDA.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights